NCT00004762View on ClinicalTrials.gov

Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

December 31, 1994

Conditions
Cholangitis, Sclerosing
Interventions
DRUG

cladribine

All Listed Sponsors
collaborator

Scripps Clinic

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004762 - Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis | Biotech Hunter | Biotech Hunter